C. Ryn

发表

Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study

C. Reilly, S. Yeh, L. Hensley, 2021, Translational vision science & technology.

Ebola virus persistence in aqueous humor and 12-month outcomes of cataract surgery in survivors of Ebola virus disease

C. Reilly, S. Yeh, E. Higgs, 2019 .

Pediatric Pathology

Jason U Tilan, A. Naranjo, J. Tsuei, 2014, Modern Pathology.

Phase II randomized trial of irinotecan/temozolomide (I/T) with temsirolimus (TEM) or dinutuximab plus granulocyte colony stimulating factor (DIN/GMCSF) in children with refractory or relapsed neuroblastoma: A report from the Children’s Oncology Group (COG).

S. Servaes, A. Naranjo, J. Maris, 2016 .

Evaluation of resources used during care of children with high-risk neuroblastoma (HR NBL) via merging of cooperative group trial data and administrative data.

A. Seif, W. London, Troy Richardson, 2014 .

Extent of Lymph Node Radiation Coverage in High-Risk Neuroblastoma Does Not Affect Clinical Outcome: A Report From the COG A3973 Study

K. Matthay, A. Davidoff, D. Haas-Kogan, 2014 .

Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

A. Naranjo, J. Gastier-Foster, K. Matthay, 2017, Cancer.

MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

A. Naranjo, J. Maris, K. Matthay, 2017, Pediatric blood & cancer.

Abstract LB-049: Low plasma levels of 13-cis-retinoic acid (isotretinoin) and its active metabolite 4-oxo-13-cis-retinoic acid are associated with lower overall survival of high-risk neuroblastoma patients

A. Naranjo, Shengping Yang, J. Villablanca, 2017 .